Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Aug;64(2):353–356. doi: 10.1038/bjc.1991.305

Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires.

P Hopwood 1, A Howell 1, P Maguire 1
PMCID: PMC1977509  PMID: 1892763

Abstract

Eighty-one patients with advanced breast cancer completed the Hospital Anxiety and Depression Scale (HADS) and Rotterdam Symptom Checklist (RSCL) to determine how well these questionnaires identified patients suffering from an anxiety state or depressive illness, compared with an independent interview by a psychiatrist who used the Clinical Interview Schedule. A threshold score was defined for each questionnaire which gave the optimal sensitivity and specificity. Seventy-five per cent of patients were correctly identified as suffering from an affective disorder by both the Rotterdam Symptom Checklist and by the Hospital Anxiety and Depression Scale. Twenty-one per cent of 'normal' patients were misclassified by the Rotterdam Checklist and 26% by the Hospital Anxiety and Depression Scale. When the HADs anxiety and depression subscales were analysed separately, the performance of the anxiety items was superior to that of the depression items. Both questionnaires were found to have good predictive value and could be used in patients with advanced cancer to help screen out those with an affective disorder.

Full text

PDF
353

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baum M., Priestman T., West R. R., Jones E. M. A comparison of subjective responses in a trial comparing endocrine with cytotoxic treatment in advanced carcinoma of the breast. Eur J Cancer. 1980;Suppl 1:223–226. [PubMed] [Google Scholar]
  2. Bell D. R., Tannock I. F., Boyd N. F. Quality of life measurement in breast cancer patients. Br J Cancer. 1985 Apr;51(4):577–580. doi: 10.1038/bjc.1985.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brinkley D. Quality of life in cancer trials. Br Med J (Clin Res Ed) 1985 Sep 14;291(6497):685–686. doi: 10.1136/bmj.291.6497.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coates A., Gebski V., Bishop J. F., Jeal P. N., Woods R. L., Snyder R., Tattersall M. H., Byrne M., Harvey V., Gill G. Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. N Engl J Med. 1987 Dec 10;317(24):1490–1495. doi: 10.1056/NEJM198712103172402. [DOI] [PubMed] [Google Scholar]
  5. Dean C. Psychiatric morbidity following mastectomy: preoperative predictors and types of illness. J Psychosom Res. 1987;31(3):385–392. doi: 10.1016/0022-3999(87)90059-6. [DOI] [PubMed] [Google Scholar]
  6. Derogatis L. R., Morrow G. R., Fetting J., Penman D., Piasetsky S., Schmale A. M., Henrichs M., Carnicke C. L., Jr The prevalence of psychiatric disorders among cancer patients. JAMA. 1983 Feb 11;249(6):751–757. doi: 10.1001/jama.249.6.751. [DOI] [PubMed] [Google Scholar]
  7. Goldberg D. P., Cooper B., Eastwood M. R., Kedward H. B., Shepherd M. A standardized psychiatric interview for use in community surveys. Br J Prev Soc Med. 1970 Feb;24(1):18–23. doi: 10.1136/jech.24.1.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gough I. R., Furnival C. M., Schilder L., Grove W. Assessment of the quality of life of patients with advanced cancer. Eur J Cancer Clin Oncol. 1983 Aug;19(8):1161–1165. doi: 10.1016/0277-5379(83)90042-1. [DOI] [PubMed] [Google Scholar]
  9. Maguire P., Tait A., Brooke M., Thomas C., Sellwood R. Effect of counselling on the psychiatric morbidity associated with mastectomy. Br Med J. 1980 Nov 29;281(6253):1454–1456. doi: 10.1136/bmj.281.6253.1454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Priestman T. J., Baum M. Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet. 1976 Apr 24;1(7965):899–900. doi: 10.1016/s0140-6736(76)92112-7. [DOI] [PubMed] [Google Scholar]
  11. Razavi D., Delvaux N., Farvacques C., Robaye E. Screening for adjustment disorders and major depressive disorders in cancer in-patients. Br J Psychiatry. 1990 Jan;156:79–83. doi: 10.1192/bjp.156.1.79. [DOI] [PubMed] [Google Scholar]
  12. Selby P. J., Chapman J. A., Etazadi-Amoli J., Dalley D., Boyd N. F. The development of a method for assessing the quality of life of cancer patients. Br J Cancer. 1984 Jul;50(1):13–22. doi: 10.1038/bjc.1984.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Tannock I. F., Boyd N. F., DeBoer G., Erlichman C., Fine S., Larocque G., Mayers C., Perrault D., Sutherland H. A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer. J Clin Oncol. 1988 Sep;6(9):1377–1387. doi: 10.1200/JCO.1988.6.9.1377. [DOI] [PubMed] [Google Scholar]
  14. Vecchio T. J. Predictive value of a single diagnostic test in unselected populations. N Engl J Med. 1966 May 26;274(21):1171–1173. doi: 10.1056/NEJM196605262742104. [DOI] [PubMed] [Google Scholar]
  15. Zigmond A. S., Snaith R. P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x. [DOI] [PubMed] [Google Scholar]
  16. de Haes J. C., van Knippenberg F. C., Neijt J. P. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer. 1990 Dec;62(6):1034–1038. doi: 10.1038/bjc.1990.434. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES